Hubei Goto Biopharm Group Co., Ltd. (SZSE: 300966)
Health Care · Biotechnology · CN
CN¥25.70
+0.86% today · +18.7% 1Y
Hubei Goto Biopharm Group Co., Ltd. (SZSE: 300966) operates in the Biotechnology industry within the Health Care sector. The company is valued at $437.59M and employs 893 people.
Over the last twelve months the share price has gained 18.7%, trading between 18.44 and 32.58.
Tweenvest scores Hubei Goto Biopharm Group Co., Ltd. across four factors: quality 58/100, value 59/100, growth 0/100, dividend 4/100. Its strongest factor is value.
300966 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $437.59M
- Revenue (TTM)
- $95.70M
- P/E
- —
- EPS
- -0.82
- Dividend yield
- 0.17%
- Beta (5Y)
- 0.57
- 52-week high
- CN¥32.58
- 52-week low
- CN¥18.44
- Avg volume (3M)
- —
- Shares outstanding
- 114.21M
- Employees
- 893
- Next earnings
- —
About Hubei Goto Biopharm Group Co., Ltd.
Hubei Goto Biopharm Co.,Ltd. is a Chinese enterprise specializing in the manufacture and distribution of active pharmaceutical ingredients (APIs) and intermediate compounds for steroid hormones. Its product line features essential starting materials such as 9a-hydroxy-4-androstenedione (9a-OHAD), bisnoralcohol (BA), sitolactone, 1,4-androstadienedione (ADD), and 4-androstenedione (4-AD). The company also provides a variety of intermediates, including those for estrogens, progesterone, non-steroidal substances, various other hormones, and corticosteroids. Furthermore, Hubei Goto Biopharm supplies additional raw materials for the pharmaceutical industry. The firm was established in Yicheng, China, in 2006.
- ISIN
- CNE100004K94
- Founded
- 2006
- Listed since
- Apr 9, 2021
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kamada Ltd.TASE: KMDA | $454.57M | ₪24.18 | -0.21% |
| Avacta Group PlcAIM: AVCT | $445.37M | £0.64 | -11.81% |
| DiaMedica Therapeutics Inc.NasdaqCM: DMAC | $443.81M | $7.99 | -2.92% |
| Tectonic Therapeutic, Inc.NasdaqGM: TECX | $440.64M | $22.71 | +0.75% |
| Myriad Genetics, Inc.NasdaqGS: MYGN | $434.25M | $4.28 | -5.73% |
| Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.SZSE: 300313 | $431.10M | CN¥12.06 | -2.51% |
| Edding Genor Group Holdings LimitedSEHK: 6998 | $430.01M | HK$1.70 | +1.80% |
| Prothena Corporation plcNasdaqGS: PRTA | $429.18M | $8.48 | +1.44% |
Figures last refreshed Oct 4, 2026.